Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptormediated apoptosis

PURPOSE: DNA repair defects due to detrimental BRCA2-mutations confer increased susceptibility towards DNA interstrand-crosslinking (ICL) agents and define patient subpopulations for individualized genotype-based cancer therapy. However, due to the side effects of these drugs, there is a need to ide...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: De Toni, Enrico N., Ziesch, Andreas, Rizzani, Antonia, Török, Helga-Paula, Hocke, Sandra, Lü, Shuai, Wang, Shao-Chun, Hucl, Tomas, Göke, Burkhard, Bruns, Christiane, Gallmeier, Eike
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2016
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891053/
https://ncbi.nlm.nih.gov/pubmed/26843614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7053
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares